Metformin does not attenuate the acute insulin-sensitizing effect of a single bout of exercise in individuals with insulin resistance
- 29 March 2014
- journal article
- clinical trial
- Published by Springer Nature in Acta Diabetologica
- Vol. 51 (5) , 749-755
Abstract
Combining metformin and exercise is recommended for the treatment of insulin resistance. However, it has been suggested that metformin blunts the insulin-sensitizing effects of exercise. We evaluated in a group of insulin-resistant patients the interactions between exercise and their daily dose of metformin. Ten insulin-resistant patients underwent insulin sensitivity assessment using intravenous glucose tolerance test after an overnight fast in the following conditions: (1) after taking their habitual morning dose of metformin (MET), (2) after 45 min of high intensity interval exercise having withheld metformin during 24 h (EX), and (3) after their habitual metformin dose plus an identical exercise bout (MET + EX). During the exercise trials (EX and MET + EX), energy expenditure and substrate oxidation were assessed by indirect calorimetry. In addition, 12-h postprandial blood glucose was measured in all three trials. Insulin sensitivity was similar between MET and EX [4.0 ± 0.8 and 4.1 ± 0.7 × 10−4 min−1 (μU mL)−1; P = 0.953] but was 43 % higher than both MET and EX after MET + EX (NS; P = 0.081). Blood glucose disappearance rate was higher after MET + EX than after MET or EX trials (1.7 ± 0.2, 1.0 ± 0.1, and 1.2 ± 0.1 % min−1, respectively; P = 0.020). There was no difference in postprandial blood glucose concentration after the three meals that followed the trials (P = 0.446). Exercise energy expenditure was 9 % higher during MET + EX than during EX (P = 0.015) partly due to increased carbohydrate oxidation. Our data suggest that habitual metformin treatment in insulin-resistant patients does not blunt the acute insulin-sensitizing effects of a single bout of exercise that on the contrary, tends to enhance it.Keywords
This publication has 20 references indexed in Scilit:
- Metformin Regulates Glucose Transporter 4 (GLUT4) Translocation through AMP-activated Protein Kinase (AMPK)-mediated Cbl/CAP Signaling in 3T3-L1 Preadipocyte CellsJournal of Biological Chemistry, 2012
- Metformin and Exercise in Type 2 DiabetesDiabetes Care, 2011
- Current understanding of increased insulin sensitivity after exercise – emerging candidatesActa Physiologica, 2011
- Combining short-term metformin treatment and one bout of exercise does not increase insulin action in insulin-resistant individualsAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Short‐term effects of metformin in type 2 diabetesDiabetes, Obesity and Metabolism, 2006
- Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 DiabetesDiabetes, 2002
- Metabolic Effects of Metformin in Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1995
- Effect of an acute bout of exercise on glucose disposal in human obesityJournal of Applied Physiology, 1990
- Effects of Prior High-Intensity Exercise on Glucose Metabolism in Normal and Insulin-resistant MenDiabetes, 1985